Literature DB >> 12654791

Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins.

Fréderic Bétis1, Patrick Brest, Véronique Hofman, Julie Guignot, Imad Kansau, Bernard Rossi, Alain Servin, Paul Hofman.   

Abstract

Ulcerative colitis and Crohn's disease are inflammatory bowel diseases thought to involve strains of Escherichia coli. We report here that two wild-type Afa/Dr diffusely adhering E. coli (DAEC) strains, C1845 and IH11128, which harbor the fimbrial F1845 adhesin and the Dr hemagglutinin, respectively, and the E. coli laboratory strain HB101, transformed with the pSSS1 plasmid to produce Afa/Dr F1845 adhesin, all induced interleukin-8 (IL-8) production and transepithelial migration of polymorphonuclear leukocytes (PMNL) in polarized monolayers of the human intestinal cell line T84 grown on semipermeable filters. We observed that after PMNL migration, expression of decay-accelerating factor (DAF, or CD55), the brush border-associated receptor for Afa/Dr adhesins, was strongly enhanced, increasing the adhesion of Afa/Dr DAEC bacteria. When examining the mechanism by which DAF expression was enhanced, we observed that the PMNL transepithelial migration induced epithelial synthesis of tumor necrosis factor alpha and IL-1beta, which in turn promoted the upregulation of DAF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654791      PMCID: PMC152057          DOI: 10.1128/IAI.71.4.1774-1783.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  75 in total

1.  Structural and functional lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli.

Authors:  I Peiffer; J Guignot; A Barbat; C Carnoy; S L Moseley; B J Nowicki; A L Servin; M F Bernet-Camard
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Structure/function studies of human decay-accelerating factor.

Authors:  W G Brodbeck; L Kuttner-Kondo; C Mold; M E Medof
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

3.  CD97 isoform expression in leukocytes.

Authors:  W Eichler
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

4.  Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis.

Authors:  P Hofman; G Le Negrate; B Mograbi; V Hofman; P Brest; A Alliana-Schmid; G Flatau; P Boquet; B Rossi
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

5.  High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?

Authors:  P Hofman; B L Hsi; S Manie; P Fenichel; A Thyss; B Rossi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.

Authors:  T Uesu; M Mizuno; H Inoue; J Tomoda; T Tsuji
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

7.  Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases.

Authors:  W Shen; H Steinrück; A Ljungh
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Prospective study of verocytotoxin-producing, enteroaggregative and diffusely adherent Escherichia coli in different diarrhoeal states.

Authors:  M G Brook; H R Smith; B A Bannister; M McConnell; H Chart; S M Scotland; A Sawyer; M Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

9.  Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells.

Authors:  G Le'Negrate; E Selva; P Auberger; B Rossi; P Hofman
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

10.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  26 in total

1.  Role of Src kinases in mobilization of glycosylphosphatidylinositol-anchored decay-accelerating factor by Dr fimbria-positive adhering bacteria.

Authors:  Christophe J Queval; Valérie Nicolas; Isabelle Beau
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; Karen A Krogfelt; Beth A McCormick
Journal:  Cell Microbiol       Date:  2011-10-27       Impact factor: 3.715

Review 4.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Afa/Dr diffusely adhering Escherichia coli strain C1845 induces neutrophil extracellular traps that kill bacteria and damage human enterocyte-like cells.

Authors:  Viviana Marin-Esteban; Isabelle Turbica; Guillaume Dufour; Nicolas Semiramoth; Aude Gleizes; Roseline Gorges; Isabelle Beau; Alain L Servin; Vanessa Lievin-Le Moal; Catherine Sandré; Sylvie Chollet-Martin
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 8.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

9.  A new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen.

Authors:  Erik J Boll; Beth A McCormick
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

10.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.